Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
2201
DELISTED
Cidara Therapeutics
CDTX
| $2.36M | ﹤0.01% |
29,483
-195
| -0.7% | -$26.6K |
|
|
MTEM
2202
DELISTED
Molecular Templates, Inc.
MTEM
| $2.36M | ﹤0.01% |
19,658
+14,854
| +309% | +$2.24M |
|
2203
Lands' End
LE
$366M
| $2.35M | ﹤0.01% |
+100,574
| New | +$1.86M |
|
2204
PUT
Halliburton
HAL
$29.6B
| $2.35M | ﹤0.01% |
50,000
-250,000
| -83% | -$12.3M |
|
2205
Healthcare Realty
HR
$6.56B
| $2.34M | ﹤0.01% |
+88,631
| New | +$2.36M |
|
2206
State Street Blackstone Senior Loan ETF
SRLN
$5.48B
| $2.34M | ﹤0.01% |
49,431
+22,916
| +86% | +$1.09M |
|
|
TBI
2207
Trueblue
TBI
$325M
| $2.34M | ﹤0.01% |
90,418
+70,706
| +359% | +$1.93M |
|
2208
Select Water Solutions
WTTR
$2.52B
| $2.33M | ﹤0.01% |
184,822
-35,694
| -16% | -$585K |
|
|
TGNA
2209
DELISTED
TEGNA Inc
TGNA
| $2.33M | ﹤0.01% |
204,603
+84,791
| +71% | +$1.16M |
|
|
VIAB
2210
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $2.33M | ﹤0.01% |
75,000
-325,000
| -81% | -$10.5M |
|
|
INVX
2211
PUT
Innovex International
INVX
$2.09B
| $2.32M | ﹤0.01% |
+51,800
| New | +$2.53M |
|
|
HSKA
2212
DELISTED
Heska Corp
HSKA
| $2.32M | ﹤0.01% |
29,357
+25,757
| +715% | +$1.89M |
|
2213
Zai Lab
ZLAB
$3.01B
| $2.31M | ﹤0.01% |
108,091
+58,536
| +118% | +$1.33M |
|
2214
Kite Realty
KRG
$5.21B
| $2.31M | ﹤0.01% |
151,360
+100,200
| +196% | +$1.62M |
|
2215
Transportadora de Gas del Sur
TGS
$4.29B
| $2.3M | ﹤0.01% |
117,569
+84,436
| +255% | +$1.76M |
|
2216
Parker-Hannifin
PH
$127B
| $2.3M | ﹤0.01% |
13,423
-583,679
| -98% | -$111M |
|
2217
Hurco Companies Inc
HURC
$148M
| $2.29M | ﹤0.01% |
49,967
+15,266
| +44% | +$683K |
|
2218
First Internet Bancorp
INBK
$240M
| $2.29M | ﹤0.01% |
61,906
+11,686
| +23% | +$445K |
|
2219
Standard BioTools
LAB
$253M
| $2.29M | ﹤0.01% |
391,249
+373,673
| +2,126% | +$2.45M |
|
2220
Zurn Elkay Water Solutions
ZWS
$8.05B
| $2.28M | ﹤0.01% |
159,532
-493,708
| -76% | -$6.77M |
|
|
ATNX
2221
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.27M | ﹤0.01% |
6,683
+3,483
| +109% | +$1.11M |
|
|
MYOV
2222
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.27M | ﹤0.01% |
106,868
+37,602
| +54% | +$572K |
|
2223
Franco-Nevada
FNV
$52.3B
| $2.27M | ﹤0.01% |
33,186
-6,900
| -17% | -$505K |
|
|
CAVM
2224
DELISTED
Cavium, Inc.
CAVM
| $2.27M | ﹤0.01% |
28,591
-172,626
| -86% | -$15.1M |
|
2225
iShares MSCI Australia ETF
EWA
$1.34B
| $2.26M | ﹤0.01% |
102,616
-31,276
| -23% | -$721K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $2.48B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.